• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者生存的地标预测:伊朗德黑兰的一个案例研究

Landmark Prediction of Survival for Breast Cancer Patients: A Case Study in Tehran, Iran.

作者信息

Alafchi Behnaz, Tapak Leili, Hamidi Omid, Poorolajal Jalal, Mahjub Hossein

机构信息

Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.

Modeling of Noncommunicable Diseases Research Center, School of Health, Hamadan University of Medical Sciences, Hamadan, Iran.

出版信息

Iran J Public Health. 2019 Dec;48(12):2249-2259.

PMID:31993394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6974853/
Abstract

BACKGROUND

Breast cancer is the first non-cutaneous malignancy in women and the second cause of death due to cancer all over the world. There are situations where researchers are interested in dynamic prediction of survival of patients where traditional models might fail to achieve this goal. We aimed to use a dynamic prediction model in analyzing survival of breast cancer patients.

METHODS

We used a data set originates from a retrospective cohort (registry-based) study conducted in 2014 in Tehran, Iran, information of 550 patients were available analyzed. A method of landmarking was utilized for dynamic prediction of survival of the patients. The criteria of time-dependent area under the curve and prediction error curve were used to evaluate the performance of the model.

RESULTS

An index of risk score (prognostic index) was calculated according to the available covariates based on Cox proportional hazards. Therefore, hazard of dying for a high-risk patient with breast cancer within the next five years was 2.69 to 3.04 times of that for a low-risk patient. The value of the dynamic C-index was 0.89 using prognostic index as covariate.

CONCLUSION

Generally, the landmark model showed promising performance in predicting survival or probability of dying for breast cancer patients in this study in a predefined window. Therefore, this model can be used in other studies as a useful model for investigating the survival of breast cancer patients.

摘要

背景

乳腺癌是女性中首位非皮肤恶性肿瘤,也是全球癌症死亡的第二大原因。在某些情况下,研究人员对患者生存情况的动态预测感兴趣,而传统模型可能无法实现这一目标。我们旨在使用动态预测模型分析乳腺癌患者的生存情况。

方法

我们使用了一个源自2014年在伊朗德黑兰进行的一项回顾性队列(基于登记)研究的数据集,对550例患者的可用信息进行了分析。采用地标法对患者生存情况进行动态预测。使用时间依赖性曲线下面积和预测误差曲线的标准来评估模型的性能。

结果

根据基于Cox比例风险的可用协变量计算出风险评分指数(预后指数)。因此,高危乳腺癌患者在未来五年内死亡的风险是低危患者的2.69至3.04倍。以预后指数作为协变量时,动态C指数值为0.89。

结论

总体而言,在本研究中,地标模型在预定义窗口内预测乳腺癌患者的生存或死亡概率方面表现出良好的性能。因此,该模型可在其他研究中作为研究乳腺癌患者生存情况的有用模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/6974853/cc255ed2d00a/IJPH-48-2249-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/6974853/a313f22c4f31/IJPH-48-2249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/6974853/96bee26d8f72/IJPH-48-2249-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/6974853/8cf660c67b69/IJPH-48-2249-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/6974853/cc255ed2d00a/IJPH-48-2249-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/6974853/a313f22c4f31/IJPH-48-2249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/6974853/96bee26d8f72/IJPH-48-2249-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/6974853/8cf660c67b69/IJPH-48-2249-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/6974853/cc255ed2d00a/IJPH-48-2249-g004.jpg

相似文献

1
Landmark Prediction of Survival for Breast Cancer Patients: A Case Study in Tehran, Iran.乳腺癌患者生存的地标预测:伊朗德黑兰的一个案例研究
Iran J Public Health. 2019 Dec;48(12):2249-2259.
2
Comparison of joint modeling and landmarking for dynamic prediction under an illness-death model.疾病死亡模型下动态预测的联合建模与地标法比较
Biom J. 2017 Nov;59(6):1277-1300. doi: 10.1002/bimj.201600235. Epub 2017 May 16.
3
Dynamic prediction and prognostic analysis of patients with cervical cancer: a landmarking analysis approach.宫颈癌患者的动态预测和预后分析:一种定标分析方法。
Ann Epidemiol. 2020 Apr;44:45-51. doi: 10.1016/j.annepidem.2020.01.009. Epub 2020 Mar 4.
4
Landmarking 2.0: Bridging the gap between joint models and landmarking.标志点 2.0:连接关节模型和标志点之间的差距。
Stat Med. 2022 May 20;41(11):1901-1917. doi: 10.1002/sim.9336. Epub 2022 Jan 31.
5
Dynamic prediction by landmarking in competing risks.基于标志点的竞争风险动态预测。
Stat Med. 2013 May 30;32(12):2031-47. doi: 10.1002/sim.5665. Epub 2012 Oct 22.
6
Dynamic landmark prediction for mixture data.动态混合数据地标预测。
Biostatistics. 2021 Jul 17;22(3):558-574. doi: 10.1093/biostatistics/kxz052.
7
Landmark risk prediction of residual life for breast cancer survival.乳腺癌生存的里程碑式残余寿命风险预测。
Stat Med. 2013 Sep 10;32(20):3459-71. doi: 10.1002/sim.5776. Epub 2013 Mar 14.
8
Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.用于指导早期乳腺癌女性辅助化疗决策的基因表达谱分析:基于证据的经济分析
Ont Health Technol Assess Ser. 2010;10(23):1-57. Epub 2010 Dec 1.
9
Landmark cure rate models with time-dependent covariates.具有时间依存性协变量的标志性治愈率模型。
Stat Methods Med Res. 2017 Oct;26(5):2042-2054. doi: 10.1177/0962280217708681. Epub 2017 Jun 19.
10
A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models.使用Cox模型和经验贝叶斯加法风险模型对伊朗南部年轻、中年和老年乳腺癌患者的生存率进行比较。
Epidemiol Health. 2017 Oct 16;39:e2017043. doi: 10.4178/epih.e2017043. eCollection 2017.

本文引用的文献

1
Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.基于免疫组织化学亚型(ER/PR/HER2)的乳腺癌生存分析:一项回顾性队列研究。
Arch Iran Med. 2016 Oct;19(10):680-686.
2
Disease-free survival in patients with non-metastatic breast cancer.非转移性乳腺癌患者的无病生存期。
Rev Assoc Med Bras (1992). 2016 Sep-Oct;62(5):407-13. doi: 10.1590/1806-9282.62.05.407.
3
Breast cancer survival among young women: a review of the role of modifiable lifestyle factors.年轻女性乳腺癌的生存情况:可改变生活方式因素的作用综述
Cancer Causes Control. 2016 Apr;27(4):459-72. doi: 10.1007/s10552-016-0726-5. Epub 2016 Mar 12.
4
Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.β受体阻滞剂、血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的使用与乳腺癌生存率:系统评价和荟萃分析。
Int J Cancer. 2016 Jul 1;139(1):212-9. doi: 10.1002/ijc.30062. Epub 2016 Mar 12.
5
Epidemiology and prognosis of breast cancer in young women.年轻女性乳腺癌的流行病学和预后。
J Thorac Dis. 2013 Jun;5 Suppl 1(Suppl 1):S2-8. doi: 10.3978/j.issn.2072-1439.2013.05.24.
6
Dynamic prediction by landmarking in competing risks.基于标志点的竞争风险动态预测。
Stat Med. 2013 May 30;32(12):2031-47. doi: 10.1002/sim.5665. Epub 2012 Oct 22.
7
Breast cancer statistics, 2011.乳腺癌统计数据,2011 年。
CA Cancer J Clin. 2011 Nov-Dec;61(6):409-18. doi: 10.3322/caac.20134. Epub 2011 Oct 3.
8
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
9
HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer.HER2 磷酸化通过 PKB 负反馈环维持,以响应乳腺癌中的抗 HER2 赫赛汀。
PLoS Biol. 2010 Dec 21;8(12):e1000563. doi: 10.1371/journal.pbio.1000563.
10
Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival.转移性乳腺癌中的脑转移:疾病特异性危险因素和生存。
Ann Oncol. 2011 Jul;22(7):1571-1581. doi: 10.1093/annonc/mdq625. Epub 2010 Nov 8.